Cart
sales@molnova.com
TINK-IN-1
CAS No. 1417795-25-5
TINK-IN-1( —— )
Catalog No. M37028 CAS No. 1417795-25-5
TINK-IN-1 is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 250 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 535 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1135 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTINK-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTINK-IN-1 is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
-
DescriptionTINK-IN-1 (Compound 9) is a potent and selective Traf2- and Nck-interacting kinase (TNIK) inhibitor with an IC50 of 8 nM. TINK-IN-1 inhibits colorectal cancer cells viability.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1417795-25-5
-
Formula Weight416.47
-
Molecular FormulaC24H24N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (300.14 mM; Ultrasonic )
-
SMILESN#CC=1C=CC(OC)=C(C1)C=2C=CN=C(C2)NC3=CC=C(C(OC)=C3)N4CCOCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ho KK, et al. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorg Med Chem Lett. 2013 Jan 15;23(2):569-73.?
molnova catalog
related products
-
Chonglou Saponin VII
Chonglou saponin VII shows inhibitory effects on cell proliferation.
-
Carboxylesterase-IN-...
Carboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases.
-
PRI-724 B
PRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.
